Independent information. England-wide.Public data. Clear sources.

NCT04498767 · OligoRARE

Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)

Registered research study with 2 identifiable England locations. See source dates, location-specific recruitment and the original study record.

Study facts

Conditions recorded
Gynecologic Cancer; Skin Cancer; Head and Neck Cancer; Sarcoma; Renal Cancer; Bladder Cancer; Upper Urinary Tract Carcinoma; Pancreatic Cancer; Hepatobiliary Cancer; Gastric Cancer; Small Bowel Cancer; Esophageal Cancer; Melanoma; Colon Cancer; Oligometastasis
Lead sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Study type
Interventional
Overall status
Recruiting · this can differ by location
Age range in the record
18 Years to Not specified
Sex eligibility field
All
Healthy volunteers accepted
No, according to the record
Phase
Na
Study record last updated
26 August 2024
Study team last verified status
2024-08

These fields are a starting point. Eligibility can include diagnosis, treatment history and other criteria shown only in the complete source record. A registry entry does not establish treatment effectiveness.

England study locations

A location is reproduced as named in the study record. A source map point can represent a town; it is not used here as a hospital entrance or to identify a care provider.

Location in the sourceLocal recruitment statusGeographic connection
University Hospitals Birmingham NHS Foundation Trust (UHB) - UHB-Queen Elisabeth Medical Centre

Birmingham · B15 2TH

RecruitingCare in Birmingham

England postcode

Royal Marsden Hospital - site: Chelsea, London

London · SW3 6JJ

RecruitingCare in Kensington and Chelsea

England postcode

Questions for the research team

  • Is this exact location currently enrolling participants, and do my circumstances meet the full criteria?
  • What visits, tests, possible risks and follow-up would participation involve?
  • Are travel costs or accessibility arrangements available?
  • How would participation affect my usual care, and what happens if I withdraw?

Source: ClinicalTrials.gov, a United States Government database. Contains OS data © Crown copyright and database right 2026. Contains National Statistics data © Crown copyright and database right 2024; ONS country boundaries (December 2024).

Source processed: 2026-09-10 09:00:04 UTC. Retrieved: 10 September 2026. ClinicalTrials.gov terms.

How we selected and connected these records

Selected registered studies with an overall status of Recruiting or Not yet recruiting and at least one England location established by postcode, recorded nation, or source coordinates within the ONS December 2024 boundary. Retained structured fields; omitted descriptions, eligibility text, contacts and non-England locations. Deduplicated identical locations. Linked local care areas only by exact postcode geography. Location points are used for nation filtering, not directions or facility matching.